Study Summary
This trial looks at whether whole body vibration can help improve the health of people with chemotherapy-induced peripheral neuropathy.
- Chemotherapy-induced Peripheral Neuropathy
- Cancer
- Blood Cancer
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
4 Primary · 16 Secondary · Reporting Duration: Before and after every whole body vibration session, up to 2 times per day, 7 days per week, for 12 weeks
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Usual Care (UC)
1 of 2
Whole body vibration (WBV)
1 of 2
Active Control
Experimental Treatment
40 Total Participants · 2 Treatment Groups
Primary Treatment: Whole Body Vibration · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the primary goal of this clinical investigation?
"This medical study, which will be monitored up to 3 months, aims to determine the accrual rate. Secondary objectives include an evaluation of [chronic pain](https://www.withpower.com/clinical-trials/chronic-pain) levels with a Brief Pain Inventory (BPI), lean body mass by dual X-ray absorptiometry scans, and fat mass also via DXA scanning." - Anonymous Online Contributor
How many individuals have registered for this experiment?
"Affirmative. Information available on clinicaltrials.gov shows that this medical investigation, posted August 5th 2019, is still seeking participants to enrol in the trial at one location with a quota of 40 patients." - Anonymous Online Contributor
Is there availability to join this clinical trial?
"Yes, up-to-date information on clinicaltrials.gov indicates that this experiment is now recruiting participants; it was originally posted online on the 5th of August 2019 and edited most recently on 26th August 2022. The researchers need 40 individuals to take part in the trial at one location." - Anonymous Online Contributor